API reference
Dihydroartemisinin
- CAS number
- 71939-50-9
- Molecular formula
- C15H24O5
- Molecular weight
- 284.35 g/mol
About this molecule
Artenimol is an artemisinin derivative and antimalarial agent used in the treatment of uncomplicated *Plasmodium falciparum* infections. It was first authorized for market by the European Medicines Agency in October 2011 in combination with [DB13941] as the product Eurartesim. Artemisinin combination therapy is highly effective against malaria and stongly recommended by the World Health Organization.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol
- InChIKey
- BJDCWCLMFKKGEE-ISOSDAIHSA-N
- SMILES
- C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C
- Other CAS numbers recorded
- 81496-82-4
- PubChem CID
- 3000518
Also known as
Artenimol · Dihydroqinghaosu · Salaxin · Santecxin · Cotexin · Alaxin · Cotecxin · Dynamax
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.